The hazardous substances ethylene glycol and diethylene glycol were found in the syrup medications.
Digital Desk: Seven Made-in-India products have been pointed out by the World Health Organisation in its investigation into the distribution of contaminated cough syrups around the globe, NDTV channel reported.
Twenty toxic substances were flagged by the
WHO investigation, and their use is responsible for more than 200 deaths worldwide. According to WHO officials speaking to NDTV, the remaining medicinal products on the list are from Indonesia.
The main manufacturers of these dangerous syrups are Maiden Pharmaceuticals, Marion Biotech, and QP Pharma Chem, all situated in Haryana. Notably, WHO has previously issued a warning about tainted medications made in India, but this time the list was released following the conclusion of a thorough study.
In its investigation, the WHO discovered significant concentrations of diethylene and ethylene glycol in cough syrups, which are causing several fatalities worldwide. After numerous deaths linked to the intake of cough syrup were recorded in African nations, India's distribution of poor medicine came to light. More than 60 children in the Gambia and about 20 in Uzbekistan died last year as a result of drugs produced in India.
The hazardous substances ethylene glycol and diethylene glycol were found in the syrup medications.
Before, a combined investigation by the US Centres for Disease Control and Prevention and the Gambia's health officials uncovered substantial evidence of a connection between the use of cough syrups made in India and the deaths of several children there.
An additional 12 deaths in Africa's Cameroon have been connected to cough syrups made in India.
In a recent event,
the Central African nation of Cameroon stated that tainted cough syrups were to blame for twelve child deaths. The authorities anticipate that using drugs made in India will cause youngsters to die.
According to Bloomberg, which obtained access to the photo given by Cameroonian health officials, the contaminated medications were produced by Riemann Labs Pvt. Ltd., which has its headquarters in Indore, Madhya Pradesh.
The medications in the image "look like ours," Riemann director Navin Bhatia told Bloomberg in a phone interview. Reimann adheres to tight quality standards, therefore there is no chance that it produced tainted medicine or even hinted at counterfeiting, he added.
Leave A Comment